{"id":"W2791191075","doi":"10.1200/jco.2018.36.5_suppl.196","title":"Time to first-line (1L) therapy discontinuation in metastatic melanoma (MM).","year":2018,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Click Chemistry and Applications","field":"Chemistry","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Discontinuation; Medicine; Pembrolizumab; Nivolumab; Internal medicine; Dabrafenib; Metastatic melanoma; Oncology; Pediatrics; Cancer; Immunotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001106562,0.0001771442,0.0004036081,0.0006178233,0.0003237009,0.0007056829,0.000319994,0.0003898015,0.002530606],"category_scores_gemma":[0.005191796,0.0001540325,0.0009588365,0.0008095303,0.0001542113,0.00046177,0.0004446355,0.0007206784,0.0003454242],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000759088,"about_ca_system_score_gemma":0.0004979175,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003508358,"about_ca_topic_score_gemma":0.004354044,"domain_scores_codex":[0.9991958,0.0001507643,0.0001372591,0.0002147395,0.0001591353,0.0001424169],"domain_scores_gemma":[0.9929029,0.001021969,0.005347461,0.0001142055,0.0002320304,0.0003814674],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.000805306,0.0000448988,0.9893063,0.0001252313,0.0001367769,0.0001492419,0.00008370962,0.0002354277,0.0001609402,0.00003106803,0.0004996972,0.008421368],"study_design_scores_gemma":[0.00003057732,0.0003079841,0.9964959,0.00006495121,0.00007205128,0.0008827651,0.00007768899,0.0005698211,0.0001472228,0.00003677185,0.001306114,0.000008171026],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9903619,0.003423826,0.0002421905,0.000168945,0.00002173118,0.00004375634,0.004326611,0.00001950525,0.0013916],"genre_scores_gemma":[0.9960448,0.0006486392,0.0001177787,0.00007644969,0.00002600209,0.0000285867,0.002751512,0.000006679437,0.0002995014],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003508358,"threshold_uncertainty_score":0.008465707,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1259341740086885,"score_gpt":0.4620217195089515,"score_spread":0.336087545500263,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}